Spire Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Sell |
916
-11
| -1% | -$1.67K | 0.01% | 862 |
|
|
2025
Q1 | $140K | Sell |
927
-19
| -2% | -$2.86K | ﹤0.01% | 924 |
|
|
2024
Q4 | $175K | Buy |
946
+9
| +1% | +$1.66K | 0.01% | 863 |
|
|
2024
Q3 | $185K | Sell |
937
-192
| -17% | -$37.8K | 0.01% | 747 |
|
|
2024
Q2 | $233K | Sell |
1,129
-6
| -0.5% | -$1.24K | 0.01% | 686 |
|
|
2024
Q1 | $308K | Sell |
1,135
-96
| -8% | -$26K | 0.01% | 657 |
|
|
2023
Q4 | $261K | Buy |
1,231
+14
| +1% | +$2.97K | 0.01% | 690 |
|
|
2023
Q3 | $239K | Buy |
1,217
+3
| +0.2% | +$588 | 0.01% | 661 |
|
|
2023
Q2 | $255K | Sell |
1,214
-22
| -2% | -$4.63K | 0.01% | 656 |
|
|
2023
Q1 | $249K | Sell |
1,236
-427
| -26% | -$86.2K | 0.01% | 664 |
|
|
2022
Q4 | $362K | Buy |
1,663
+97
| +6% | +$21.1K | 0.02% | 425 |
|
|
2022
Q3 | $308K | Buy |
1,566
+59
| +4% | +$11.6K | 0.02% | 431 |
|
|
2022
Q2 | $323K | Sell |
1,507
-2,082
| -58% | -$446K | 0.01% | 608 |
|
|
2022
Q1 | $1.02M | Sell |
3,589
-58,449
| -94% | -$16.6M | 0.03% | 383 |
|
|
2021
Q4 | $23.4M | Buy |
62,038
+1,231
| +2% | +$464K | 0.52% | 38 |
|
|
2021
Q3 | $25.1M | Sell |
60,807
-287
| -0.5% | -$119K | 0.67% | 31 |
|
|
2021
Q2 | $22.6M | Sell |
61,094
-229
| -0.4% | -$84.7K | 0.61% | 33 |
|
|
2021
Q1 | $17.7M | Buy |
+61,323
| New | +$17.7M | 0.47% | 48 |
|